Epidermal growth factor receptor localized to exosome membranes as a possible biomarker for lung cancer diagnosis

Author： Yamashita T.   Kamada H.   Kanasaki S.   Maeda Y.   Nagano K.   Abe Y.   Inoue M.   Yoshioka Y.   Tsutsumi Y.   Katayama S.   Inoue M.   Tsunoda S.  

Publisher： Govi-Verlag

ISSN： 0031-7144

Source： Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol.68, Iss.12, 2013-12, pp. : 969-973

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Epidermal Growth Factor Receptor Inhibitors in Non-Small Cell Lung Cancer

By Dancey Janet E.  

Drugs, Vol. 67, Iss. 8, 2007-01 ,pp. : 1125-1138

Adis International

Access to resources Recommend Favorite

Therapeutic Approaches for the Treatment of Epidermal Growth Factor Receptor Mutated Lung Cancer

By  

Current Cancer Drug Targets, Vol. 18, Iss. 8, 2018-10 ,pp. : 773-791

Bentham Science Publishers

Access to resources Recommend Favorite

Gefitinib is an effective treatment for patients with non-small-cell lung cancer (NSCLC) and mutations in the epidermal growth factor receptor

By  

Inpharma, Vol. 1, Iss. 1547, 2006-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Optimal Management of Patients with Non-Small Cell Lung Cancer and Epidermal Growth Factor Receptor Mutations

By Lin Chia-Chi   Yang James Chih-Hsin  

Drugs, Vol. 71, Iss. 1, 2011-01 ,pp. : 79-88

Adis International

Access to resources Recommend Favorite

Epidermal growth factor receptor inhibitors in the treatment of non-small cell lung cancer

By Agelaki Sofia   Georgoulias Vassilis  

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 4, 2005-11 ,pp. : 855-874

Informa Healthcare

Access to resources Recommend Favorite